Location History:
- Shizuoka, JP (2016 - 2021)
- Aichi, JP (2014 - 2023)
Company Filing History:
Years Active: 2014-2023
Title: Kazuhiko Nonomura: Innovator in Cancer and Cachexia Treatment
Introduction
Kazuhiko Nonomura is a prominent inventor based in Aichi, Japan, known for his significant contributions to medical science. He holds a total of seven patents, focusing primarily on innovative treatments for cancer and cachexia. His work has the potential to greatly impact the lives of patients suffering from these conditions.
Latest Patents
Nonomura's latest patents include a selective EP4 receptor antagonistic substance for the treatment of cancer. This invention provides a medicament that reduces cancer by utilizing a compound with inhibitory activities against the prostaglandin E2 receptor (EP4 receptor). The patent outlines a method for treating cancer by administering the compound or its pharmaceutically acceptable salt to humans or animals. Additionally, he has developed a ghrelin receptor agonist for the treatment of cachexia. This invention also involves a compound or its pharmaceutically acceptable salt, which can be used in combination with other active agents to treat cachexia effectively.
Career Highlights
Throughout his career, Nonomura has worked with notable companies such as Askat Inc. and Raqualia Pharma Inc. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and research.
Collaborations
Nonomura has collaborated with esteemed colleagues, including Shinichi Koizumi and Takako Okumura. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking medical treatments.
Conclusion
Kazuhiko Nonomura's innovative work in the field of medicine, particularly in cancer and cachexia treatment, showcases his dedication to improving patient outcomes. His patents reflect a commitment to advancing healthcare through scientific research and collaboration.